- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Growth Stocks
Global Pharmaceuticals & Biotech Top Growth Stocks
Results
65
65 companies
Axsome Therapeutics
Market Cap: US$5.1b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$104.39
7D
2.7%
1Y
28.8%
Alnylam Pharmaceuticals
Market Cap: US$42.1b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$326.09
7D
4.1%
1Y
34.0%
PharmaResearch
Market Cap: ₩5.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩493,500.00
7D
0.7%
1Y
231.2%
Camurus
Market Cap: SEK 36.0b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 606.50
7D
2.2%
1Y
2.1%
Oscotec
Market Cap: ₩1.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩29,000.00
7D
3.9%
1Y
-20.4%
PharmaEssentia
Market Cap: NT$182.6b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$548.00
7D
3.8%
1Y
-5.8%
Xbrane Biopharma
Market Cap: SEK 392.2m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.26
7D
9.1%
1Y
0.8%
Bonesupport Holding
Market Cap: SEK 18.4b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 280.00
7D
5.3%
1Y
3.3%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥11.7b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥37.22
7D
-1.4%
1Y
-33.5%
argenx
Market Cap: €28.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€469.80
7D
0.8%
1Y
16.4%
Ardelyx
Market Cap: US$882.9m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.92
7D
8.0%
1Y
-48.2%
Xiamen Amoytop Biotech
Market Cap: CN¥29.3b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥72.11
7D
2.5%
1Y
36.3%
Mereo BioPharma Group
Market Cap: US$422.9m
A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
MREO
US$2.71
7D
-1.1%
1Y
-25.3%
WuXi XDC Cayman
Market Cap: HK$50.0b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$41.60
7D
1.8%
1Y
140.5%
Legend Biotech
Market Cap: US$6.4b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$35.49
7D
4.8%
1Y
-22.9%
Boji Medical TechnologyLtd
Market Cap: CN¥3.5b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥9.22
7D
5.3%
1Y
10.7%
Kexing Biopharm
Market Cap: CN¥7.6b
Engages in the research and development, production, and sale of recombinant protein drugs and microbial preparations in China and internationally.
688136
CN¥38.22
7D
-4.9%
1Y
127.1%
ARS Pharmaceuticals
Market Cap: US$1.8b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$17.45
7D
5.3%
1Y
99.9%
Vanda Pharmaceuticals
Market Cap: US$281.7m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.72
7D
5.6%
1Y
-15.4%
Soleno Therapeutics
Market Cap: US$4.2b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$83.78
7D
2.9%
1Y
98.1%
Achieve Life Sciences
Market Cap: US$110.8m
A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
ACHV
US$2.26
7D
-41.1%
1Y
-52.7%
Evoke Pharma
Market Cap: US$5.3m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$2.60
7D
4.0%
1Y
-54.1%
ACADIA Pharmaceuticals
Market Cap: US$3.7b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$21.57
7D
-4.0%
1Y
34.5%
Chongqing Zhifei Biological Products
Market Cap: CN¥46.9b
Chongqing Zhifei Biological Products Co., Ltd.
300122
CN¥19.65
7D
1.2%
1Y
-28.9%
Oxford Biomedica
Market Cap: UK£335.8m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£3.17
7D
3.1%
1Y
6.6%
Arcutis Biotherapeutics
Market Cap: US$1.6b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$14.02
7D
-2.6%
1Y
46.7%
Lipigon Pharmaceuticals
Market Cap: SEK 15.9m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.11
7D
11.3%
1Y
-60.8%
CorMedix
Market Cap: US$930.4m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$12.32
7D
-25.6%
1Y
187.9%
aTyr Pharma
Market Cap: US$447.7m
A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
ATYR
US$5.07
7D
1.8%
1Y
225.0%
Kidswell Bio
Market Cap: JP¥12.2b
Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.
4584
JP¥252.00
7D
-37.8%
1Y
85.3%
Orchid Pharma
Market Cap: ₹36.2b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹739.55
7D
5.7%
1Y
-35.0%
GNI Group
Market Cap: JP¥172.5b
Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.
2160
JP¥3,435.00
7D
-7.8%
1Y
46.8%
Shanghai Rightongene Biotechnology
Market Cap: CN¥1.4b
Shanghai Rightongene Biotechnology Co., Ltd.
688217
CN¥25.30
7D
6.6%
1Y
30.2%
Invivyd
Market Cap: US$87.2m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$0.71
7D
2.0%
1Y
-40.4%
Hugel
Market Cap: ₩3.9t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩364,000.00
7D
-1.1%
1Y
62.9%
SIGA Technologies
Market Cap: US$461.5m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.52
7D
5.3%
1Y
-13.6%